Member Info for appletree1

This placing was largely expected and 20p was predicted too so no reason for panic selling/ selling now. Even the placees ( Wonga lender or not) wont be selling for an average price less than they paid, so if the placees are selling now at the 20p break even level then that implies this is already into the final flush of forward sold stock. Apart from that the TW shorting crew are presumably trying to milk the last penny or so before closing their shorts and talking their book here to do so alongside those that are expressing their justified annoyance, but logically the SP should start to recover very shortly.

Are we not basically still waiting for this to IPO on NASDAQ? So far all we have is OTC which is not NASDAQ. If this has yet to list/ IPO on NASDAQ then wouldn't the company set the price per share at that stage - eg 5 USD? The 20/1 reverse split just determines number of shares we each have to be listed but the initial NASDAQ price at launch could still be 5 USD without any need for further consolidation.

My comment from last week: 1,824,978,590 was the number of issued ordinary shares as at 18 February as stated on our AGM notice. ( That doesn't tally with LSE, perhaps because it may include some performance shares that have been issued but not yet listed ?? ). There may have been more performance shares issued since then. As per previous discussion, it would help if GCAT do a TVR (Total Voting Rights form) filing to clarify.

I cannot see any mention that Kenya use a securitized share system like the NASDAQ ADRses so I assume that it is simply a parallel pool of shares that is substantially synced to move up and down with the SP on the UK LSE by mutual agreement. So, I don't think that it will reduce our free float. The 15% makes more sense as 15% of the NSE listed share capital.

1,824,978,590 was the number of issued ordinary shares as at 18 February as stated on our AGM notice. The London Stock Exchange and the landing page of this website doesn't reflect that number of shares, showing MCAP as £14.94M. Presumably that means that some of the shares are issued but not listed yet. Is a TVR needed to bring the London Stock Exchange fully up to date on the number of shares in issue and listed (as well as us)?

The last indication of ordinary share capital issued was on the AGM notice - 1,824,978,590.

Based on what Iamagoldbuyer said, the lowest price trades today (at 11:03) were discounted bed-and-ISA buy-backs. If that is correct it would indicate that the MMs are the primary culprits - dropping the SP to enable cheap buy-ins for the ISA providers rather than any seller(s) driving the drop.

Was hoping the bed-and ISAs that dipped the SP yesterday would surge the SP today but looks like the providers have negotiated a deal with the MMs enabling them a good re-entry. On the plus side, at least we now know that a large part of the current dip is a false dip.

Bought more at the predicted 0.897p low. The SP could start recovering fairly strongly from tomorrow onward as the new tax year starts.

And today is still tax year end, so probably still some last-minute bed-and ISA selling today. Like most stocks, there is fair prospect of uptick tomorrow and/or next few days as the new ISA year starts. On that premise I've added more today.

I see that peer Core Lithium on ASX is now valued at the equivalent of GB Pounds 1.5 Billion with a DFS resource of 7.3 Mt ore (at 1.30% Li20) and is due to start production at the end of this year. On the face of it ALL's planned dual listing on ASX is likely to give ALL better recognition of the fair value of its MRE of 30Mt resource than the current sole listing on LSE does. That may further help to push the SP higher as the Ewoyaa mine gets closer and closer to DFS completion and production. We own half our resource but are fully funded through the DFS and to production by Piedmont. Based on peer comparison, is there any reason to doubt (black swan events and market crashes aside) that ALL will likely be worth nearer to a billion pounds by the end of this year/ early next year and the share price potentially tripled whether a buy-out occurs or not?

Sell price 0.977p versus buy price 0.975p. MMs are now paying a premium to acquire shares.

The 0.95p was the SP paid by the Clear Capital investors in the recent placing in February. 1.12p was the average figure for the placing stated on the RNS based on one investor paying 1.25p.

The 0.95p was the SP paid by the C the recent placing in February. 1.12p was the average figure for the placing stated on the RNS based on one

The 4.7 Million shares bought at 1.05p yesterday at 11.30 AM is now reported together with an 8 Million shares trade at 1.0p at 4.23 PM yesterday. Probably the latter is a sell, balancing yesterday's buys.

The two trades at 4:21pm reported after close at around 2M shares didn't affect the price of the last three trades of the day, so I am not convinced they are both sells. They were for similar amounts to each other and with the second trade priced slightly higher than the first. They possibly are simply roll-over trades or bed-and-ISA where the shares are sold and re-bought. [ If we don't dip to 90p bid at open on Monday then that is likely the correct explanation].

Today was a low volume day but significantly the heavy selling has seemingly stopped so that we recovered over 10% on the bid today with ease. If that is pretty much the end of the distressed selling then we will quickly see the last of these bargain placing-level buy prices and should be in for further good recovery next week and have a strong base for rising from when the assay results come through and new ISA year begins.

OlderandWiser, on your point that new Institutions other than Orca may be relatively risk averse and hold off from buying into GCAT until all of GCAT's medium term targets have been met you assume that the SP wont move up significantly without new IIs. The MCAP of GCAT is still very small, and most micro-caps at this level don't have any IIs but still readily double and treble in size with good news. Already we have quite a number of PIs who individually each hold a percent of the company. The doubling and trebling of SP and MCAP this year could easily come from PIs topping up and fresh PIs investing into the company as it meets the various milestones, not waiting until all of the medium term goals have been achieved.

Looking at the chat on HUM the debt servicing and their production problems /poor AISC issues have been a drain on their profitability - but over and above that they also face a risk of potential loss of a mine through economic sanctions due to the on-going conflict in Mali. HUM is clearly not a direct bench-mark for GCAT. Kenya and Tanzania are solid, politically stable states in Africa. Mali is not and has been in a state of War since 2012 and with EU sanctions imposed against it since January. If anything, GCAT is undervalued when compared to the seemingly bombed out current price of HUM.

OK, so the 6M share trade at 95p at close on Friday reported just now maybe explains the missing sell volume on Friday.